DJIA Losers: Travelers, Procter and Gamble, and Merck
The Dow Jones Industrial Average (NYSEARCA:DIA) is down today 0.54% and stands at 12,667. The Dow hasn’t been able to keep gains during this mixed earnings week.
Travelers (NYSE:TRV): The financial sector is getting hit today as GNP numbers came in below expectations. Subdued numbers from T. Rowe Price and a downgrade of Hartford Financial is making matters worse. TRV shares recently traded at $57.97, down $0.73, or 1.24%. They have traded in a 52-week range of $45.97 to $64.17. Volume today was 2,217,390 shares versus a 3-month average volume of 3,946,400 shares. The company’s trailing P/E is 14.83, while trailing earnings are $3.91 per share.
Don’t Miss: Procter & Gamble: Lowering Projections for 2012.
Procter and Gamble (NYSE:PG) beat 2nd quarter earning expectations, but has lowered its future forecasts as a consequence of higher commodity prices and a strong dollar, which makes their items more expensive overseas. PG shares recently traded at $64.30, down $0.5, or 0.77%. They have traded in a 52-week range of $57.56 to $67.72. Volume today was 7,135,279 shares versus a 3-month average volume of 10,436,000 shares. The company’s trailing P/E is 16.33, while trailing earnings are $3.94 per share.
Merck (NYSE:MRK): Tom Aspray of Forbes believes many drug companies are attractively priced, and Merck is one of them, based on technical analysis. Having said that, Merck already has had a nice run since August. MRK shares recently traded at $38.49, down $0.29, or 0.75%. They have traded in a 52-week range of $29.47 to $39.43. Volume today was 7,838,086 shares versus a 3-month average volume of 16,302,300 shares. The company’s trailing P/E is 28.14, while trailing earnings are $1.37 per share.
Investing Insights: 2 Healthcare Stocks Shooting Higher Following Earnings Reports.